CD8A and diffuse large B-cell lymphoma: Overall, our study highlights that TIM3/Galectin-9 pathway plays an essential role in CD8+TILs exhaustion and the immune escape of DLBCL, and is a valuable prognosticator and can facilitate the development of novel immunotherapy.